7-107690212-A-G
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000441.2(SLC26A4):c.1238A>G(p.Gln413Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000311 in 1,608,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250842Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135548
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1456730Hom.: 0 Cov.: 29 AF XY: 0.00000276 AC XY: 2AN XY: 725054
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74344
ClinVar
Submissions by phenotype
Pendred syndrome Pathogenic:3
- -
- -
Variant summary: SLC26A4 c.1238A>G (p.Gln413Arg) results in a conservative amino acid change located in the SLC26A/SulP transporter domain (IPR011547) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250842 control chromosomes. c.1238A>G has been reported in the literature in multiple individuals affected with hearing loss (examples: Wang_2014, Yazdanpanahi_2015). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 25290043, 25015771). ClinVar contains an entry for this variant (Variation ID: 370080). Based on the evidence outlined above, the variant was classified as pathogenic. -
Autosomal recessive nonsyndromic hearing loss 4 Pathogenic:1
- -
not provided Pathogenic:1
This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 413 of the SLC26A4 protein (p.Gln413Arg). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with SLC26A4-related conditions (PMID: 20137612, 21961810, 23185506, 24248179, 25015771, 25266519, 25290043, 25372295, 26752218). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 370080). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC26A4 protein function. Experimental studies have shown that this missense change affects SLC26A4 function (PMID: 26752218). This variant disrupts the p.Gln413 amino acid residue in SLC26A4. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18285825, 19017801). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Hearing loss, autosomal recessive Pathogenic:1
- -
Pendred syndrome;C3538946:Autosomal recessive nonsyndromic hearing loss 4 Pathogenic:1
PM2_Supporting+PS3_Supporting+PM3_VeryStrong -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at